Nonprofit · EIN 86-1884515
DAVOS ALZHEIMERS COLLABORATIVE INC
Tax-exempt · WAYNE, PA 19087
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2025 | 990 | $12,470,622 | $16,083,398 | -$3,612,776 | $8,470,178 | $577,289 | $7,892,889 |
| December 31, 2024 | 990 | $9,016,882 | $10,394,563 | -$1,377,681 | $13,372,417 | $1,870,549 | $11,501,868 |
| December 31, 2023 | 990 | $8,484,685 | $9,009,933 | -$525,248 | $14,067,138 | $1,186,024 | $12,881,114 |
Financial details: 990 for the year ended December 31, 2025
Revenue
- Contributions, gifts and grants
- $12,186,383
- Program service revenue
- $60,000
- Investment income
- $224,239
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $3,542,155
- Salaries, compensation and benefits (total)
- $0
- Professional fundraising fees
- $0
- Legal fees
- $183,815
- Accounting fees
- $207,171
- Travel
- $1,298,502
- Program services (functional)
- $14,834,609
- Management and general (functional)
- $496,089
- Fundraising (functional)
- $752,700
Balance sheet and other
- Total assets, start of year
- $13,372,417
- Total assets, end of year
- $8,470,178
- Total liabilities, end of year
- $577,289
- Net assets, end of year
- $7,892,889
- Net assets without donor restrictions
- $3,998,205
- Net assets with donor restrictions
- $3,894,684
- Gross receipts
- $12,470,622
- Employees
- 0
- Volunteers
- 3
- Year formed
- 2020
- State of legal domicile
- DC
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| GEORGE VRADENBURG | CHAIR & PRESIDENT Trustee or director, Officer | 20 | $0 |
| ANDREW HOLZAPFEL | COO (SEE SCHEDULE O) Trustee or director, Officer | 30 | $0 |
| FREDA LEWIS HALL | TREASURER Trustee or director, Officer | 1 | $0 |
990 for the year ended December 31, 2024: 3 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| GEORGE VRADENBURG | CHAIR & PRESIDENT Trustee or director, Officer | 20 | $0 |
| ANDREW HOLZAPFEL | COO (SEE SCHEDULE O) Trustee or director, Officer | 30 | $0 |
| FREDA LEWIS HALL | TREASURER Trustee or director, Officer | 1 | $0 |
990 for the year ended December 31, 2023: 3 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| GEORGE VRADENBURG | CHAIR & PRESIDENT Trustee or director, Officer | 20 | $0 |
| ANDREW HOLZAPFEL | COO (SEE SCHEDULE O) Trustee or director, Officer | 30 | $0 |
| FREDA LEWIS HALL | TREASURER Trustee or director, Officer | 1 | $0 |
Address and contacts
- Address (IRS master file)
- 155 E LANCASTER AVE, WAYNE, PA 19087-3525
- In care of
- % GEORGE VRADENBURG
- Principal officer (990 for 2025)
- GEORGE VRADENBURG, 155 EAST LANCASTER AVENUE, WAYNE, PA 19087
- Signed the 990
- GEORGE VRADENBURG, CHAIR & PRESIDENT
- Phone
- (703) 599-9617
- Return prepared by
- GELMAN ROSENBERG & FREEDMAN
Mission
DAC IS LEADING THE LARGEST GLOBAL RESPONSE OF ITS KIND, DRIVING SCIENTIFIC DISCOVERY AND ALIGNING HEALTH SYSTEMS TO HELP PEOPLE WORLDWIDE, INCLUDING THOSE IN LOW RESOURCED ENVIRONMENTS LEFT OUT OF PREVIOUS EFFORTS TO FIGHT ALZHEIMER'S. (SEE SCHEDULE O)WE ARE COMMITTED TO TRANSFORMING ALZHEIMER'S RESEARCH, PREVENTION AND CARE THROUGH PROVEN PRIVATE-PUBLIC MODELS, SUCH AS GAVI, CEPI AND THE GLOBAL FUND.
Program accomplishments
- THE DAVOS ALZHEIMER'S COLLABORATIVE'S SYSTEM PREPAREDNESS PROGRAM AIMS TO STRENGTHEN HEALTHCARE SYSTEMS' ABILITY TO IDENTIFY AND ADDRESS ALZHEIMER'S DISEASE (AD) AND RELATED DEMENTIAS (ADRD) EARLY. KEY INITIATIVES INCLUDE THE EARLY DETECTION FELLOWSHIP, WHICH OFFERS TECHNICAL ASSISTANCE AND FUNDING TO HEALTHCARE ORGANIZATIONS (HCOS) TO IMPLEMENT THE EARLY DETECTION BLUEPRINT, FOSTERING COLLABORATION AMONG SELECTED SITES TO OVERCOME BARRIERS AND ENHANCE EARLY DETECTION. THE PROGRAM ALSO INCLUDES THE BRAIN HEALTH NAVIGATOR INITIATIVE, DESIGNED TO PILOT A BRAIN HEALTH NAVIGATOR MODEL IN SIX HCOS TO SUPPORT TIMELY CARE FOR PATIENTS WITH COGNITIVE DECLINE. ADDITIONALLY, THE ACCURATE DIAGNOSIS PROGRAM AIMS TO INCREASE THE USE OF NEW DIAGNOSTIC TOOLS, HELPING HEALTHCARE SYSTEMS ADOPT MORE EFFECTIVE METHODS FOR DIAGNOSING AD/ADRD. THESE EFFORTS ARE SUPPORTED BY SIGNIFICANT FUNDING AND ARE INTENDED TO IMPROVE SYSTEM PREPAREDNESS THROUGH OUTREACH, TRAINING, AND THE CREATION OF PRACTICAL TOOLKITS FOR HEALTHCARE PROVIDERS.OVERALL, OUTPUTS INCLUDE PEER-REVIEWED PUBLICATIONS, SYMPOSIUMS, POLICY COMMUNICATIONS, AND AN OPEN-ACCESS "BLUEPRINT" FOR AD/ADRD EARLY DETECTION AND SYSTEM PREPAREDNESS. DAC ALSO COLLABORATES WITH OTHER ORGANIZATIONS TO ADDRESS COMMON BARRIERS AND PROMOTE BEST PRACTICES ACROSS HEALTH SYSTEMS.Expenses $13,167,569 · grants $3,538,155
- THE DAVOS ALZHEIMER'S COLLABORATIVE'S GLOBAL COHORT DEVELOPMENT PROGRAM FOCUSES ON BUILDING A DIVERSE AND SUSTAINABLE NETWORK OF COHORTS TO ADVANCE ALZHEIMER'S DISEASE (AD) AND RELATED DEMENTIAS (ADRD) RESEARCH. THIS INCLUDES PARTNERSHIPS SUCH AS THE COLLABORATION WITH AGA KHAN UNIVERSITY IN NAIROBI, KENYA, WHERE COGNITIVE TESTS, SALIVA-BASED POLYGENIC RISK SCORES, AND DIGITAL COGNITIVE ASSESSMENTS ARE BEING VALIDATED IN EAST AFRICAN POPULATIONS TO CREATE A CLINICAL TRIAL-READY COHORT. IN SOUTH KOREA, DAC HAS ACQUIRED BLOOD SAMPLES FROM 300 PARTICIPANTS IN A HIGHLY CHARACTERIZED COHORT, ADVANCING THE VALIDATION OF BLOOD-BASED BIOMARKERS (BBMS) FOR GLOBAL USE. THE PROJECT ALSO INCLUDES ACCESS TO 1,000 BLOOD SAMPLES FROM A LONG-STANDING COHORT IN THE LATAM/CARIBBEAN REGION FOR AD BLOOD BIOMARKER VALIDATION, AS WELL AS A LARGE-SCALE CLINICAL TRIAL RECRUITMENT EFFORT IN THE DOMINICAN REPUBLIC, WITH OVER 14,000 PARTICIPANTS ACROSS URBAN AND RURAL SETTINGS.FURTHER EXPANDING GLOBAL RESEARCH, DAC IS DEVELOPING SCALABLE APPROACHES IN EGYPT FOR EARLY DETECTION, MONITORING, AND RISK REDUCTION OF AD, WHILE IN INDIA, THE "EYE-DEA STUDY" IS USING CATARACT SURGERY CLINICS TO ASSESS OCULAR, SPEECH, AND OLFACTORY BIOMARKERS RELATED TO COGNITIVE IMPAIRMENT. IN CHILE, DAC IS COLLECTING A WIDE RANGE OF DATA FROM A 9,000-PERSON COHORT TO GENERATE LOCAL VALIDATION DATA FOR BLOOD BIOMARKERS AND DIGITAL COGNITIVE ASSESSMENTS, PARTICULARLY FOCUSING ON THE IMPACT OF PESTICIDE USE AND EXPOSURE TO NEUROTOXINS. THESE EFFORTS ARE HELPING TO ENSURE THAT AD RESEARCH IS INCLUSIVE OF DIVERSE POPULATIONS AND ADAPTABLE TO LOCAL SETTINGS, WITH THE AIM OF IMPROVING EARLY DETECTION, DIAGNOSIS, AND TREATMENT ON A GLOBAL SCALE.Expenses $1,667,040 · grants $4,000 · revenue $60,000
- THE DAVOS ALZHEIMER'S COLLABORATIVE'S GLOBAL CLINICAL TRIAL PROGRAM IS MAINTAINING A NETWORK OF MORE THAN 30 EUROPEAN SITES ORGANIZED TO ACCELERATE STUDIES AND IMPLEMENT NOVEL TRIAL DESIGNS. THIS EFFORT IS PART OF DAC'S BROADER GOAL TO BUILD INFRASTRUCTURE FOR FUTURE PHARMACOLOGICAL AND NON-PHARMACOLOGICAL TRIALS GLOBALLY. THROUGH THE GLOBAL COHORT DEVELOPMENT PROGRAM, DAC IS WORKING TO CREATE CLINICAL TRIAL-READY POPULATIONS BY 2026, ENSURING THAT DIVERSE AND WELL-CHARACTERIZED COHORTS ARE PREPARED FOR BOTH TYPES OF INTERVENTIONS. THIS WILL EXPAND OPPORTUNITIES FOR GLOBAL CLINICAL TRIALS, ENHANCING THE ABILITY TO TEST NEW TREATMENTS AND APPROACHES IN ALZHEIMER'S DISEASE (AD) AND RELATED DEMENTIAS (ADRD) ACROSS VARIED POPULATIONS AND SETTINGS.
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | 990 on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 86-1884515
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2021
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Voluntary health associations and medical disciplines (G83)
- Assets (IRS master file)
- $8,470,178
- Income (IRS master file)
- $12,470,622
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2025 | $12,470,622 | $16,083,398 | $8,470,178 | XML |
| 990 | December 2024 | $9,016,882 | $10,394,563 | $13,372,417 | XML |
| 990 | December 2023 | $8,484,685 | $9,009,933 | $14,067,138 | XML |
| 990 | December 2022 | $9,767,900 | $8,101,186 | $14,995,945 | IRS |
| 990 | December 2021 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 86-1884515).
Questions about DAVOS ALZHEIMERS COLLABORATIVE INC
- What is the EIN of DAVOS ALZHEIMERS COLLABORATIVE INC?
- The employer identification number (EIN) of DAVOS ALZHEIMERS COLLABORATIVE INC is 86-1884515.
- Is DAVOS ALZHEIMERS COLLABORATIVE INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2021.
- Are donations to DAVOS ALZHEIMERS COLLABORATIVE INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does DAVOS ALZHEIMERS COLLABORATIVE INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of DAVOS ALZHEIMERS COLLABORATIVE INC due?
- The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did DAVOS ALZHEIMERS COLLABORATIVE INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2025.
- Who is the principal officer of DAVOS ALZHEIMERS COLLABORATIVE INC?
- The 990 for the year ended December 31, 2025 names GEORGE VRADENBURG.
- Who are the officers and directors of DAVOS ALZHEIMERS COLLABORATIVE INC?
- The 990 for the year ended December 31, 2025 lists 3 people; 0 received compensation from the organization.
- How much revenue does DAVOS ALZHEIMERS COLLABORATIVE INC have?
- On its 990 for the year ended December 31, 2025 it reported revenue of $12,470,622, expenses of $16,083,398 and total assets of $8,470,178 at year end.
Other nonprofits in WAYNE
- CHARITDI EIN 85-0653600 · last filed 990-N for 2025
- FRANKIES FIGHT EIN 20-3583952 · last filed 990-N for 2024
- NEUROTRAUMA FOUNDATION EIN 75-2970706 · last filed 990-N for 2025
- PAISBOA HEALTH BENEFIT TR EIN 46-7526272 · last filed 990 for 2025
- HAMILTON FAMILY CHARITABLE TRUST EIN 82-1671948 · last filed 990-PF for 2024
- E RHODES AND LEONA B CARPENTER FOUNDATION EIN 51-0155772 · last filed 990-PF for 2024
- AO NORTH AMERICA INC EIN 37-1901892 · last filed 990 for 2024
- VALLEY FORGE MILITARY ACADEMY FOUNDATION EIN 23-1178880 · last filed 990 for 2025
All nonprofits in WAYNE · Pennsylvania · Voluntary health associations and medical disciplines